Page last updated: 2024-08-25

sofosbuvir and Hepatorenal Syndrome

sofosbuvir has been researched along with Hepatorenal Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, A; Daugherty, TJ; Higgins, JP; Perumpail, RB; Pham, EA; Wong, RJ	1

Other Studies

1 other study(ies) available for sofosbuvir and Hepatorenal Syndrome

Article	Year
A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis. Digestive diseases and sciences, 2016, Volume: 61, Issue:1 Topics: Antiviral Agents; Biopsy; Drug Therapy, Combination; End Stage Liver Disease; Hepatitis C; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Male; Middle Aged; Recurrence; Renal Dialysis; Simeprevir; Sofosbuvir; Time Factors; Treatment Outcome	2016

Article

Year

A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis.

Digestive diseases and sciences, 2016, Volume: 61, Issue:1

Topics: Antiviral Agents; Biopsy; Drug Therapy, Combination; End Stage Liver Disease; Hepatitis C; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Male; Middle Aged; Recurrence; Renal Dialysis; Simeprevir; Sofosbuvir; Time Factors; Treatment Outcome

2016